Analgesia Disorder Clinical Trial
Official title:
A Randomized, Double Blind, Placebo-controlled, Multiple Dose Study to Assess the Efficacy, Safety and Pharmacokinetics of Oral Nalbuphine, an Oral Soft Capsule, for Post-hemorrhoidectomy Pain Management
The purpose of this study is to assess the effectiveness, safety and pharmacokinetics of Oral Nalbuphine in the treatment of postoperative pain following hemorrhoidectomy.
• Primary Efficacy Endpoint: Pain assessment calculated as the area under the curve of VAS pain intensity scores through 48 hours. • Secondary Efficacy Endpoints: 1. Consumption of diclofenac (Day 1-2) via Intramuscular Injection (IM injection). 2. Time from the end of operation to the first IM injection diclofenac dose 3. Brief Pain Inventory (BPI). 4. Patient satisfaction. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02192151 -
Study of PHN131 in Healthy Volunteers
|
N/A | |
| Recruiting |
NCT02195271 -
Neuroplasticity:Melatonin and Transcranial Current Stimulation in Healthy Subjects.
|
Phase 2 | |
| Completed |
NCT02122510 -
Transverse Abdominal Block for Analgesia in Casarean Section
|
N/A | |
| Completed |
NCT03107585 -
Intermediate Cervical Block Under Ultrasound for Thyroid Surgery: Impact on Per and Postoperative Opioid Consumption
|
N/A | |
| Completed |
NCT02446301 -
A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02315261 -
Effectiveness of Epidural Anesthesia for Thoracic and Abdominal Surgery
|
||
| Completed |
NCT02468128 -
A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management
|
Phase 2/Phase 3 | |
| Completed |
NCT01785823 -
Fentanyl Background Infusion for Acute Postoperative Pain
|
N/A |